Biotechnology offers enormous opportunities for the future of food, materials, and production. From precision fermentation to bio-based ingredients and alternative proteins, the technology is evolving rapidly. Yet one message stood out clearly at the BTRUST conference: the biggest challenge is not the technology itself, but trust and implementation.
For Urban Crop Solutions (UCS), this is a familiar reality. Across many projects, we observe that innovative solutions often perform perfectly from a technical perspective, yet their success is ultimately determined by acceptance, regulation, and scalability.
The insights from BTRUST therefore strongly resonate with the transition we are currently making as a company: from technology-driven innovation towards reliable, reproducible implementation in real-world environments.
Trust as the Real Bottleneck
A key conclusion of the conference is that biotechnology frequently encounters barriers related to perception. Many consumers and stakeholders still associate biotech with something “unnatural” or insufficiently understood. At the same time, studies show that a majority remains open to innovation—provided that benefits are clearly demonstrated and risks are communicated transparently.
The difference, therefore, does not lie in the technology itself, but in how it is explained, applied, and embedded within society. Transparency—including acknowledging uncertainties—is essential to building trust.
For companies, this means that innovation is no longer purely a technical exercise. It requires a broader approach in which communication, governance, and stakeholder engagement play a central role.
Co-creation as a Structural Approach
A second key insight is the importance of co-creation. Instead of developing technology in a top-down manner and communicating only at the final stage, BTRUST advocates a process in which stakeholders—from consumers to policymakers—are involved from the outset.
This approach includes multiple structured phases:
- Identification of relevant stakeholders
- Active engagement through workshops and dialogue
- Analysis of perceptions and barriers
- Joint development of solutions
By involving stakeholders early, innovations are better aligned with real needs and gain faster acceptance. However, the conference also emphasized that co-creation must be professionally structured and goal-oriented—it should be treated as an essential part of the innovation process, not as a formality.
What Does This Mean for UCS?
For UCS, this confirms a key strategic direction: our role is not only to build systems, but to enable the reliable implementation of new technologies.
Our own experience clearly shows:
- Technology is rarely the limiting factor
- The main challenges lie in scaling, regulation, and market acceptance
- Successful projects require robust, controlled, and reproducible environments
As a result, UCS is evolving from a supplier of cultivation systems into a broader role as an integrator of controlled production environments.
Where the sector often focuses on innovation in isolation, the real added value lies in translating that innovation into a working reality:
- From lab to pilot
- From pilot to scalable production
- From concept to an industrially reliable process
Bridging the Gap Between R&D and Reality
A recurring theme at the conference was the so-called “valley of death” between research and industrial application. Many (bio)technological innovations remain stuck in the pilot phase due to the complexity and capital intensity of scaling.
This is precisely where engineering companies like UCS play a crucial role. There is a growing need for:
- Pilot and testing facilities
- Flexible and modular production environments
- Controlled climate systems for bioprocesses
This type of infrastructure enables companies to validate, optimize, and ultimately bring their technologies to market. It is not just about hardware, but about creating controlled environments in which innovation can operate reliably
A Broader Perspective on Our Market
One final reflection from the conference: the traditional positioning of indoor growing or vertical farming has become too narrow.
The same core technologies—climate control, automation, and system integration—are equally relevant in applications such as:
- Fermentation
- Foodtech
- Biobased production
- Research infrastructure
The market is evolving towards controlled bioproduction infrastructure: environments where biological processes are controlled, scalable, and reproducible.
For UCS, this does not represent a change in direction, but rather an expansion of context in which our existing expertise is applied.
Conclusion
The BTRUST conference reinforces what many companies are already experiencing: innovation alone is not enough. Success is determined by how reliably a technology can be implemented, understood, and accepted.
This is exactly where UCS positions itself. We do not build technology for the sake of technology—we create environments in which innovation can truly perform, today and at scale.
From trust to implementation, and from innovation to impact: this is where the future of biotech and foodtech will be decided.